(Preceptor and Preceptor’s Department or Division)

• Oyebimpe Adesina, MD (Jason Gotlib, Stan Schrier, Hematology)
  Long term sequelae of Sickle Cell disorder and mitigating factors in affected adults
  
• Anosheh Afghahi, MD (Melinda Telli, Oncology)
  DNA repair targeted strategies in triple-negative and hereditary breast cancer
• Alexey Aleshin, MD, MBA
  Clinical fellow with July 2015 start; will begin research in January 2017
  
• Jennifer Caswell-Jin, MD
  Clinical fellow; will begin research in July 2015
  
• Mark P. Chao, MD, PhD (Irving Weissman, Pathology; Ravi Majeti, Hematology)
  Modeling hematologic malignancies through induced pluripotent stem cells
• Viola Chen, MD
  Clinical fellow with July 2015 start; will begin research in January 2017
  
• Jody Chuang, MD, PhD (Joel Neal, Heather Wakelee, Oncology)
  Clinical trials and other studies in thoracic oncology
  
• Brian Dietrich, MD
  Clinical fellow with July 2015 start; will begin research in January 2017
• Joshua Gruber, MD, PhD (James Ford, Oncology and Michael Snyder, Genetics)
  Measuring somatic mutation rate in patients at high risk for malignancy
  
• Robert W. Hsieh, MD, PhD (Michael Clarke, Oncology)
  RNAi screening in primary human breast cancer cells to identify regulators of oncogenic growth
  
• David Iberri, MD
  Clinical fellow; Hematology Clinic and Med 9
• Tyler P. Johnson, MD, PhD
  Clinical fellow
• Adel Kardosh, MD, PhD
  Clinical fellow; will begin research in January 2016
• Gregory Kaufman, MD
  Clinical fellow with July 2015 start; will begin research in January 2017
  
• David Matthew Kurtz, MD (Ash Alizadeh, Oncology; Sanjiv Gambhir, Radiology)
  ARTS (Advanced Residency Training Program) Bioengineering PhD Program - Monitoring therapeutic responses in lymphoma
• Ryan Lynch, MD
  Clinical fellow; will begin research in January 2016
• Michael Mancuso, MD, PhD
  Clinical fellow with July 2015 start; will begin research in January 2017
• Siddhartha Mitra, MD, PhD (Michael Snyder, Genetics)
  Understanding the evolution of cancer in response to treatment through integrated longitudinal Omics
• Rupa Narayan, MD (Bruno Medeiros, Hematology; Ronald Levy, Oncology)
  Analysis of Immunological Responses in Acute Leukemia 
  
• Wendy Pang, MD, PhD (Irving Weissman, Pathology & Stem Cell Biology; Judith Shizuru, BMT)
  Clinical fellow; will begin research in October 2015
  Targeting blood-forming stem cells in myelodysplastic syndrome
  
• Mary-Elizabeth Muchmore Percival, MD (Bruno Medeiros, Hematology)
  Improving outcomes in acute myeloid leukemia through clinical trials using novel molecularly targeted agents
  
• Ameen A. Salahudeen, MD, PhD (Calvin Kuo, Hematology)
  Modeling aerodigestive malignancies through primary organoid culture
• Sumit  A. Shah, MD, MPH
  Clinical fellow; will begin research in January 2016
• Tanaya Shree, MD, PhD
  Clinical fellow; will begin research in March 2016
• Loretta S. Sullivan-Chang, MD (Dimitri Colevas, Oncology)
  Molecular, epidemiological, clinical trials, and health services studies regarding the role of human papillomavirus in head and neck malignancies
• Brian Sworder, MD, PhD
  Clinical fellow with July 2015 start; will begin research in January 2017
  
• Tian Yi Zhang, MD, PhD
  Clinical fellow; will begin research in January 2016
• Jeffrey Zweig, MD
  Clinical fellow with July 2015 start; will begin research in January 2017

• Michael Khodadoust, MD, PhD (Ronald Levy, Ash Alizadeh, Oncology)
  Anti-tumor immune responses in lymphoma
  
• Sujata Narayanan, MD (Sandy Srinivas, Oncology)
  Early phase clinical trials, prostate cancer genomics and clinical trials in advanced bladder cancer
  
• Sukhmani Padda, MD (Heather Wakelee, Oncology)
  Early phase trials in thoracic oncology and immunotherapy
• Manali Patel, MD (Oncology)
  GI Oncology research
  
• Yu Wong, MD, PhD (Mark Davis, Microbiology and Immunology)
  Design of novel approach to measure T cell repertoire. Translational research in breast cancer